Back to search

Article

A novel assessment method for COVID-19 humoral immunity duration using serial measurements in naturally infected and vaccinated subjects

2021-12-29

Abstract excerpt

<h4>Background</h4> It is crucial for medical decision-making and vaccination strategies to collect information on sustainability of immune responses after infection or vaccination, and how long-lasting antibodies against SARS-COV-2 could provide a humoral and protective immunity, preventing reinfection with SARS-CoV-2 or its variants. The aim of this study is to present a novel method to quantitatively measure an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7e414770-351a-5e05-bd67-d3ded6abdbbf
DOI
10.1101/2021.12.28.21268183
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A novel assessment method for COVID-19 humoral immunity duration using serial measurements in naturally infected and vaccinated subjectsDOI 10.1101/2021.12.28.21268183
Quantifying post-vaccination protective anti-SARS-CoV-2 IgG antibodies in blood and saliva with a fully automated, high throughput digital immunoassaySemantic proximity
Predicting antibody kinetics and duration of protection against SARS-CoV-2 following vaccination from sparse serological dataSemantic proximity
Longitudinal analyses after COVID-19 recovery or prolonged infection reveal unique immunological signatures after repeated vaccinationsSemantic proximity
Distinguishing SARS-CoV-2 infection and vaccine responses up to 18 months post-infection using nucleocapsid protein and receptor-binding domain antibodiesSemantic proximity
Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case seriesSemantic proximity
Antibody Persistence in the Six Months Following SARS-CoV-2 Infection Among Hospital WorkersSemantic proximity
Differential antibody dynamics to SARS-CoV-2 infection and vaccinationSemantic proximity
Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2Semantic proximity
Long-Term Persistence of IgG Antibodies in recovered COVID-19 individuals at 18 months and the impact of two-dose BNT162b2 (Pfizer-BioNTech) mRNA vaccination on the antibody responseSemantic proximity
Clinical and laboratory considerations: Determining an antibody-based composite correlate of risk for reinfection with SARS-CoV-2 or severe COVID-19Semantic proximity
Kinetics of the humoral immune response to SARS-CoV-2: comparative analytical performance of seven commercial serology testsSemantic proximity
Influence of past infection with SARS-CoV-2 on the response to the BioTech/Pfizer BNT162b2 mRNA vaccine in health care workers: kinetics and durability of the humoral responseSemantic proximity
Select a neighboring publication to make it the new centre.